ExpreS2ion Biotech Holding AB (publ) ExpreS2ion Biotech Holding AB (publ)

ExpreS2ion Biotech Holding AB (publ)

EXPRS2

Rank in Stocks #31191
Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its... Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
Share Price
$0.09629119
Last synced: 2026-11-12
Market Cap
$3.47M
Change (1 day)
-4.00%
Change (1 year)
-95.04%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade ExpreS2ion Biotech Holding AB (publ) (EXPRS2)

Category

Healthcare
Revenue for ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
Revenue in Sep 2026 TTM: $481.19K
According to ExpreS2ion Biotech Holding AB (publ)'s latest financial reports, its current revenue (TTM) is $481.19K. In 2025 the company's revenue was $396.34K, an increase over its 2024 revenue of $273.19K. Revenue is the total income a company makes from selling goods or services; unlike earnings, no expenses are subtracted.
Revenue history for ExpreS2ion Biotech Holding AB (publ) from 2013 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $481.19K 21.41%
2025 $396.34K 45.08%
2024 $273.19K -60.91%
2023 $698.83K 43.27%
2022 $487.76K -63.92%
2021 $1.35M 112.43%
2020 $636.36K -57.04%
2019 $1.48M 49.24%
2018 $992.63K -17.14%
2017 $1.20M 133.95%
2016 $512.04K 0.00%
2015 0.00 -100.00%
2014 $847.58K -18.10%
2013 $1.03M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$31.21M 6,385.18%
US
$12.99B 2,699,191.37%
US
$2.53B 524,641.56%
US
$15.74B 3,271,861.50%
AU
$9.40B 1,952,658.02%
BE

Questions about ExpreS2ion Biotech Holding AB (publ)'s revenue

What is ExpreS2ion Biotech Holding AB (publ)'s revenue?

ExpreS2ion Biotech Holding AB (publ)'s revenue over the last twelve months is $481.19K, as of Sep 2026.

What was ExpreS2ion Biotech Holding AB (publ)'s revenue in 2025?

In 2025, ExpreS2ion Biotech Holding AB (publ)'s revenue was $396.34K, 45.08% more than in 2024 ($273.19K).

How has ExpreS2ion Biotech Holding AB (publ)'s revenue changed since 2020?

From 2020 to 2025, ExpreS2ion Biotech Holding AB (publ)'s revenue went from $636.36K to $396.34K, an average decline of 9.04% a year.

How does ExpreS2ion Biotech Holding AB (publ)'s revenue compare with similar companies?

ExpreS2ion Biotech Holding AB (publ)'s revenue ($481.19K) is lower than that of all 5 similar companies listed above. The highest among them is CSL Limited, with $15.74B.